
Progyny (PGNY) Stock Forecast & Price Target
Progyny (PGNY) Analyst Ratings
Bulls say
Progyny is in a stable position due to consistent utilization and consumption of ART cycles, strong client retention, and a compelling valuation. However, potential economic uncertainty and competition could impact their business, and changes in government regulations could also be a risk factor. The upcoming implementation of an IVF mandate in California presents a new revenue opportunity, and the company's existing network should give it an advantage in capturing market share.
Bears say
Progyny is a competitive company operating in the reproductive benefits market. However, as its largest clients account for a significant portion of its revenue and a significant number of its clients are in the technology industry, changes to these clients or within the industry could negatively impact the company's financials. Additionally, changes to healthcare laws and regulations could also harm the company's business and operating results. Furthermore, uncertainties in the healthcare industry could lead to adverse impacts on Progyny's business.
This aggregate rating is based on analysts' research of Progyny and is not a guaranteed prediction by Public.com or investment advice.
Progyny (PGNY) Analyst Forecast & Price Prediction
Start investing in Progyny (PGNY)
Order type
Buy in
Order amount
Est. shares
0 shares